Mackay Shields LLC Deciphera Pharmaceuticals, Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$32.73 - $47.95 $922,985 - $1.35 Million	-28,200 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $383,705 - $538,935	-9,500 Reduced 25.2%	28,200 $1.26 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $258,850 - $330,900	-5,000 Reduced 11.71%	37,700 $2.15 Million
Q3 2020 Nov 04, 2020	BUY	$43.8 - $58.16 $854,100 - $1.13 Million	19,500 Added 84.05%	42,700 $2.19 Million
Q2 2020 Jul 31, 2020	BUY	$37.05 - $65.03 $859,559 - $1.51 Million	23,200 New	23,200 $1.39 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.